In memory of our Founder, Paul G. Allen

Learn More

Paul G. Allen, 1953-2018

“Paul’s vision and insight have been an inspiration to me and to many others both here at the Institute that bears his name, and in the myriad of other areas that made up the fantastic universe of his interests. He will be sorely missed. We honor his legacy today, and every day into the long future of the Allen Institute, by carrying out our mission of tackling the hard problems in bioscience and making a significant difference in our respective fields.”

Allan Jones
President and CEO, Allen Institute



Data Stories | A tiny brain structure with an outsized role in neurological disorders

February 8, 2019

Neuroscientist Emily Sylwestrak’s studies of the habenula could one day shed light on the biology of addiction. It all began with a chance observation she made sifting through data from the Allen Institute.


Cell Shorts | A new window into heart cells

January 30, 2019

See how Christopher Chen used the Allen Cell Collection to study the development of sarcomeres in heart muscle cells.


New CRISPR-based technique in mice upends rules of genetic inheritance

January 23, 2019

‘Active genetics,’ the parent technique of controversial gene drives, could speed biomedical research, improve mouse models of human disease

Press Release

Allen Institute names two new executives

January 30, 2019

Todd Peterson, Ph.D., joins as Chief Scientific Officer and Lauren Hackett, MPA, as Chief Operations Officer


Allen Institute 2018 year in review

December 21, 2018

A look back at milestones of the year, from launching a new division to celebrating 15 years of impact

Press Release

Announcing the Allen Institute for Immunology, a new research endeavor focused on human immune health and disease

December 12, 2018

Seeded by $125 million donation by the late Paul G. Allen, the Allen Institute for Immunology will study human immune health, cancer, and autoimmune diseases